Paul Polman: "Be the change you want to see"

IESE Insight ◽  
2014 ◽  
pp. 41-45
Author(s):  
Paul Polman ◽  
Jordi Canals Margalef
Keyword(s):  
2021 ◽  
Author(s):  
Yafang Guo ◽  
Hong Lu ◽  
Jing Gan ◽  
Dongdong Li ◽  
Jiandong Gao ◽  
...  

Abstract Background: Jiangniaosuan formula (JNSF) is commonly used in China for treating hyperuricemia, but there is little research-based evidence to support its use. This randomized controlled trial aims to assess the efficacy and safety of JNSF.Methods: A total of 72 patients with hyperuricemia will be selected and randomly assigned in a ratio of 1:2 to receive either Western medicine i.e., febuxostat 40 mg (WG group; n = 24) or Chinese herbal medicine group, i.e., Jiangniaosuan formula + febuxostat 20 mg (WJNSG; n = 48). After 12 weeks, the WJNSG will be randomly divided into two groups of 24 patients each; one group (WJNSG; n = 24)still will receive febuxostat 20 mg + Jiangniaosuan formula and the other group(JNSG; n = 24) will continue to receive Jiangniaosuan formula+Placebo. Participants will be followed up at 4-week intervals. The primary outcome will be the change in serum uric acid level, and the secondary outcome will be the change in Traditional Chinese Medicine (TCM) syndrome scores. Serum creatinine, blood glucose, and insulin levels will also be measured.Discussion: We hypothesize that patients with hyperuricemia will benefit from JNSF. This study will provide evidence-based recommendations for clinicians.Dissemination: The results will be published in a peer-reviewed journal and disseminated by academic conferences.Trial registration : This trial is registered with ClinicalTrials.gov, number ChiCTR2000041083. 22 Registered on 3 May 2021.


Author(s):  
Christine A. Heisler ◽  
Katrina Mark ◽  
Sarah M. Temkin
Keyword(s):  

2020 ◽  
Vol 29 (9) ◽  
pp. 11-15
Author(s):  
Lois Elfman
Keyword(s):  

2013 ◽  
Vol 01 (01) ◽  
pp. 032-036
Author(s):  
Raman Shetty ◽  
Biranchi Jena ◽  
Adibabu Kadithi

Abstract Introduction:Diabetes is an emergency in slow motion in India. There is an urgent need of improving awareness and education on diabetes in the community and the social scientist working in the community health are the important group to make this happen. Objectives:To assess the prevalence of diabetes among the social scientists and measure their knowledge, attitude, and practice (KAP) on diabetes. Materials and Methods:A delegate of social scientists attending a national conference on social science and health were screened for random blood sugar and a survey was conducted through a structured self-answered questionnaire on KAP in diabetes. Excel Microsoft Office 2010 package was used for descriptive analysis. Results:A total of 245 social scientists attended the conference; of them, 211 (86%) social scientists voluntarily participated in diabetes screening, and among them, 99 (47%) voluntarily responded on KAP questionnaire. Prevalence rate of diabetes among social scientists was found to be 9.5% and the study revealed that the knowledge was fair, attitude was positive, and practice was good among the social scientists working in the field of social health. Conclusion:The social scientists could be the Change Agents for the changing diabetes in the community through appropriate strategies involving them.


2003 ◽  
Vol 9 (3) ◽  
pp. 37-49 ◽  
Author(s):  
Patrick Dawson

ABSTRACTOrganisational change stories are often constructed around a linear series of ‘successful’ events that serve to show the company in a positive light to any interested external party. These stories of company success sanitize complex change processes and offer data for change experts to formulate neat linear prescriptions on how to best manage change. This article criticizes this position and argues that change is a far more dynamic political process consisting of competing histories and ongoing multiple change narratives which may vie for dominance in seeking to be the change story. A central aim is to identify and unpack narratives of change in order to highlight a number of theoretical and methodological implications for management research. It is argued that post-hoc rationalized stories should not be used as a knowledge base for prescriptive lessons or theoretical developments, nor should research data simply be presented as a single authentic story of change. The need to study change overtime and to accommodate multiple stories that may be reshaped, replaced and modified raise critical issues of data collection and data analysis, as well as important questions on the place of the conventional case study as a conveyor of research findings. As such, the article calls for the more widespread use of the concept of ‘competing histories’ and ‘multiple change narratives’ in longitudinal studies that seek to explain processes of organisational change.


2020 ◽  
Vol 12 ◽  
pp. 117957351989947
Author(s):  
Nima Ahmed ◽  
Vitor A Queiroz Mauad ◽  
Olga Gomez-Rojas ◽  
Ammu Sushea ◽  
Gelanys Castro-Tejada ◽  
...  

Background and rationale: Stroke is considered the most common cause of adult disability. Intensive rehabilitation protocols outperform nonintensive counterparts. The subacute stroke phase represents a potential window to recovery. Virtual reality (VR) has been shown to provide a more stimulating environment, allowing for increased patient compliance. However, the quality of current literature comparing VR with standard therapies is limited. Our aim is to measure the impact of VR versus standard therapy on the recovery of the upper limb motor function in patients with stroke in the early subacute recovery phase. Method: This is a randomized, controlled trial that will assign 262 patients to tailor-made standard rehabilitation (TMSR) or TMSR plus immersive VR device. The trial will be conducted in an urban rehabilitation clinic in the United States with expertise in the management of poststroke patients. Patients will be 18 to 70 years of age and in the early subacute period (30-90 days post ischemic stroke). The primary outcome will be the change of Fugl-Meyer Assessment—Upper Extremity (FMA-UE) score, measured at baseline and 13 weeks after randomization. The secondary outcome will be the change in the UK Functional Independence Measure and Functional Assessment Measure (UK FIM-FAM) score at the same time points. Discussion: If the use of VR in the rehabilitation of patients with stroke proves to have a significant impact on their motor recovery, it will constitute an extremely important step into decreasing the functional impairment associated with stroke and the related health care expense burden.


Sign in / Sign up

Export Citation Format

Share Document